Tanning peptides: melanotan injections and nasal sprays explained

Both came out of the same University of Arizona program in the 1980s. Melanotan-1 is a 13 amino acid linear analog of alpha-MSH with two stabilizing substitutions, later developed as afamelanotide. Melanotan-2 is a shortened, cyclized 7 amino acid version that is smaller and more potent. The difference that matters is receptor selectivity. Melanotan-1 acts mainly on MC1R, the receptor on skin melanocytes. Melanotan-2 is a broad agonist across MC1R, MC3R, MC4R and MC5R; MC4R in the brain produces the erections and appetite suppression, and central melanocortin signaling in the brainstem produces the nausea.

In practice melanotan-1 tans with mild nausea and flushing and nothing else, needs more peptide per dose, and works a little slower: first darkening at one to two weeks and full shade at three to four with some UV. Melanotan-2 shows darkening in one to two weeks and a full tan in two to three, at lower doses and lower cost, with the full list of side effects. Both clear from blood within hours and build pigment cumulatively from repeated doses.

Nasal tanning sprays are almost always melanotan-2, often sold with no ingredient list under names like nasal tanner or tanning mist. Nasal absorption of peptides is low and variable, and the melanotan-2 compound page describes intranasal use as unreliable for that reason. A spray delivers an unknown fraction of whatever is in the bottle, so a user cannot know whether a given day's dose was 100 mcg or 500 mcg. People respond by spraying more, which makes the nausea and the pigment effect less predictable.

The quality problem is worse than for vials. Injectable melanotan at least ships as a powder with a stated milligram content, and a buyer can look for a certificate of analysis. Sprays sold on TikTok and Instagram typically have neither, and regulators who have tested them have warned that they may contain unlisted ingredients or be contaminated. None of this makes injectable melanotan safe; it makes the spray the worst version of an unapproved product.

Community protocols for melanotan-2 start at 0.25 mg or less to test the nausea response, hold there until it fades, then step up to 0.5 mg daily for a two to three week loading phase. Once the shade is reached, maintenance is 0.5 to 1 mg once or twice a week. Melanotan-1 protocols report 0.5 mg daily for the first week, then 1 mg daily for a two to four week loading phase, 0.5 mg every other day for fair or sensitive skin, and 0.5 to 1 mg once or twice weekly to maintain. Many people load with melanotan-2 for speed and switch to melanotan-1 to maintain with fewer side effects.

Both are injected subcutaneously in the evening on a light stomach so the nausea passes during sleep, with two or three short UV sessions a week during loading, because the peptide primes melanocytes but UV brings the pigment out. A 10 mg vial in 2 mL of bacteriostatic water gives 5 mg per mL, or 50 mcg per unit on a U-100 syringe, so 0.25 mg is 5 units and 0.5 mg is 10 units; the reconstitution guide and the calculator cover other combinations. Many people stop over winter; the tan fades over one to two months once dosing stops.

Melanotan-2's side effects cluster in the hour after a dose because the peptide clears in five to six hours. Nausea and sometimes vomiting are close to universal for the first several doses. Flushing, yawning, stretching and fatigue are common. Men get spontaneous erections, both sexes report more libido, and appetite drops through the same MC4R pathway that obesity drugs like setmelanotide target. Melanotan-1 produces mild nausea and flushing and none of the sexual or appetite effects.

The pigment effects belong to both. Existing moles and freckles darken, new freckles appear, and pigmentation can come in unevenly on the face, scars and sun damaged areas. Alcohol worsens the nausea, photosensitizing drugs such as doxycycline and retinoids raise burn risk during the deliberate UV exposure, and GLP-1 drugs stack appetite loss and nausea with melanotan-2 until people stop eating. PT-141 vs melanotan-2 explains why combining either with PT-141 doubles the MC4R load for nothing.

Case reports describe new and changing melanocytic lesions, including melanoma, in melanotan-2 users. Causation has not been established, and nobody has followed users long enough to know. The mechanistic worry is real on its face: the peptide stimulates every melanocyte in the body, including those in atypical moles, and users add deliberate UV on top. The counterpoint is also real: melanotan-1 was developed as photoprotection, human pilot data showed fewer sunburn cells and less UV induced DNA damage at treated sites, and eumelanin absorbs UV.

The practical response is to photograph the skin before starting and get a dermatologist baseline for anyone with many moles or a family history of melanoma. Both compounds are listed as an avoid for anyone with a personal melanoma history or many atypical moles. A mole that changes by the usual criteria of asymmetry, irregular border, uneven color, growing diameter or evolution gets checked, and the tan is not a reason to skip sunscreen.

Melanotan-2 is not approved as a medicine in any country and is sold as a research chemical. The UK MHRA has said repeatedly that melanotan products are unlicensed and that selling them is illegal, Australia's TGA has warned that they are not approved and has acted against sellers, and several EU regulators have issued similar warnings. Possession for personal use is generally not a crime; selling it as a tanning product is. In the US it is unapproved and sold as a research reagent, with no FDA review of what is in the vial.

Melanotan-1 has an approved form, which confuses the picture. Afamelanotide is approved in the EU since 2014 and by the FDA since 2019 as Scenesse, a slow release implant placed under the skin by a clinician roughly every two months, for erythropoietic protoporphyria, a genetic condition where sunlight causes severe pain. The injectable powder sold for tanning is the same peptide without the implant, the approval or the manufacturing oversight.

Neither compound is on the WADA Prohibited List as of 2026, and workplace drug tests do not look for them, as do peptides show up on a drug test explains. The legal exposure is in buying, importing and selling.

The recent wave of warnings is about the spray format specifically. UK Trading Standards bodies and the MHRA have warned in the last two years that nasal tanning sprays are unlicensed medicines marketed to young people through social media, that their melanotan-2 content and dose are unknown, and that samples may be contaminated with other substances. Australia's TGA has issued its own warnings, and imports can be seized at the border. The common thread is a drug being sold as a cosmetic with no manufacturer accountable for it.

The regulators' position is also the practical summary. A nasal tanning spray from a social media account is an unknown quantity of an unapproved peptide in a format that absorbs unpredictably, with none of the skin monitoring that even the injectable crowd treats as standard. Anyone set on a tanning peptide will find the injectable forms described on the compound pages with known doses, still unapproved and still carrying every side effect on this page. Sunless tanners based on dihydroxyacetone are the only tan-without-UV product approved as a cosmetic, which is not glamorous but is correct. How to buy peptides and are peptides safe cover sourcing and risk for any research peptide.